Investing Profile

Jocelyn Goldfein(902)

VCInvestor
Managing Director at Zetta Venture Partners
jocelyngoldfein.comSan Francisco, California
Photo of Jocelyn Goldfein, Managing Director at Zetta Venture Partners
Your Intro Paths to Jocelyn Goldfein

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Jocelyn Goldfein's investing connections

Picture
Picture
Picture

79 Investors

Connected to Satya Patel (Homebrew), Aileen Lee (Cowboy Ventures), Charles Hudson (Precursor Ventures), and 76 other investors on Signal.

Find Jocelyn Goldfein on

cb
Current Investing Position
Zetta Venture Partners Managing Director
Investment Range
$750K - $4.0M
Sweet Spot
$1.5M
Investments On Record
20
Current Fund Size
$160M

Jocelyn Goldfein is on these Sector & Stage Rankings

Jocelyn Goldfein's Investments On Record (14)

CompanyStageDateRound SizeTotal Raised
Featureform
SeedDec 2023$6M
Pre SeedJan 2021$2M
$8M
Co-investors: Rob May
Golioth
SeedMay 2023$5M
Pre SeedFeb 2021$2M
$7M
Co-investors: Nicholas Adams (Differential Ventures), Suraj Patel (Bow Capital), Philip O'Connor (Blackhorn Ventures), Peter Livingston (Unpopular Ventures), Amir Shevat (Innovation Endeavors)
Trustero
SeedMar 2022$8M
$8M
Co-investors: Ashmeet Sidana (Engineering Capital), In Sik Rhee (Vertex Ventures)
Promethium
Series AFeb 2022$26M
Series UnknownJan 2020$6M
SeedOct 2018$3M
$35M
Co-investors: Ganesh Bell (Insight Partners), Bogomil Balkansky (Sequoia Capital), Alex Kahn (Generation Ventures), Graham Brooks (.406 Ventures)
Finite State
Series AMay 2020$13M
$63M
Co-investors: Sameer Reddy (Energy Impact Partners), Lisa Lambert (National Grid Partners), Juan Muldoon (Energize Ventures)
Opsani
Series AAug 2019$10M
Seed RoundApr 2018$4.7M
SeedApr 2018$5M
$20M
Aptology
SeedJan 2019$8M
$8M
Co-investors: Warren Weiss (WestWave Capital)
Nutanix Beam
Series AAug 2017$3M
$3M
Co-investors: Sanjay Nath (Blume Ventures)

most interested in

Focused on "intelligent enterprise" - B2B startups leveraging proprietary data to deliver compounding value to their customers. Often, not always, AI.

not interested in

No consumer, no life sciences. Media/entertainment/sports pretty unlikely.